Zantac Litigation News
State-Court Mass Tort · Bellwether Trials Expected 2027

Zantac Litigation:
Key 2025–2026 Updates After Federal MDL Dismissal

Over 5,000 active cases in California’s JCCP No. 5150, with additional active dockets in Delaware and Illinois. State courts are allowing claims to proceed where the federal MDL was dismissed — bellwether trials expected in 2027. Our firm is accepting cases nationwide.

Zantac (ranitidine) was recalled after testing revealed it could degrade into NDMA — a potent carcinogen. Plaintiffs allege that manufacturers knew ranitidine was chemically unstable, that NDMA levels increased during storage and at elevated temperatures, and that these cancer risks were never disclosed to consumers. While the federal MDL was dismissed on expert-exclusion grounds, state courts have reached the opposite conclusion — and active litigation continues in thousands of cases nationwide.
5,000+ Active cases in California JCCP No. 5150
3+ Active state-court dockets (CA, DE, IL)
2027 Bellwether trials expected
NDMA Carcinogen formed by ranitidine degradation

Federal vs. State Courts

Why State-Court Litigation Is Where the Action Is

The Zantac litigation has a unique procedural posture: the federal MDL was dismissed after the judge excluded plaintiffs’ general-causation experts, but state courts — applying different evidentiary standards — have ruled the opposite way, allowing expert testimony and keeping thousands of cases alive.

Federal MDL No. 2924 — S.D. Florida

Federal MDL: Dismissed

  • Judge excluded plaintiffs’ general-causation experts under Daubert
  • Without expert testimony, all claims were effectively dismissed
  • Does not bind state courts operating under different evidentiary rules

JCCP No. 5150 — Alameda County, California

California: 5,000+ Cases Active

  • Judge Evelio Grillo ruled plaintiffs’ experts may testify
  • Over 5,000 active cases under coordinated proceedings
  • Discovery ongoing; bellwether trials expected in 2027

Delaware Superior Court

Delaware: Claims Proceeding

  • Court denied defendants’ motions to dismiss in 2025
  • Bladder, stomach, liver, and esophageal cancer claims allowed to proceed
  • Discovery orders compelling production of stability data and internal communications
The federal dismissal does not end your claim. State courts are applying independent standards and have consistently allowed plaintiffs’ expert testimony. If you used Zantac and developed cancer, viable claims remain in California, Delaware, Illinois, and other state courts.

Latest Developments · 2025–2026

What Is Happening in State-Court Zantac Litigation

  • Discovery orders compelling key evidence — courts have ordered production of stability testing data, NDMA-formation analyses, and internal communications regarding the recall
  • Delaware motions to dismiss denied (2025) — bladder, stomach, liver, and esophageal cancer claims are all proceeding in Delaware Superior Court
  • California JCCP fully active — over 5,000 cases under coordinated proceedings before Judge Grillo in Alameda County, with bellwether selection underway
  • Illinois state-court cases active — additional coordinated proceedings in Illinois courts expanding the overall docket
  • Bellwether trials expected in 2027 — early state-court verdicts will establish case values and drive settlement negotiations across all active dockets

Eligibility

Are You a Victim? Who May Qualify?

You may qualify if you used Zantac (ranitidine) — whether prescription or over-the-counter — and were later diagnosed with a qualifying cancer. Both short-term and long-term users may be eligible depending on their diagnosis and exposure history.

Qualifying Cancer Diagnoses

  • Bladder cancer
  • Stomach cancer
  • Liver cancer
  • Pancreatic cancer
  • Esophageal cancer
  • Colorectal cancer

General Eligibility Factors

  • Used Zantac (ranitidine) — prescription or OTC
  • Developed a qualifying cancer diagnosis
  • Diagnosis documented by a physician
  • Able to identify approximate duration and frequency of use

Legal Theories & Damages

Liability & What You Can Recover

Liability Legal Theories

  • Failure to warn
  • Defective design
  • Negligent misrepresentation
  • Breach of implied warranty
  • Negligent failure to recall
  • Consumer protection statute violations

Damages What You Can Recover

  • Medical expenses (past and future)
  • Lost income and reduced earning capacity
  • Pain and suffering
  • Emotional distress
  • Wrongful death damages
  • Punitive damages for reckless conduct

Our Firm Is Now Accepting Zantac Cancer Cases

We represent individuals nationwide in active state-court Zantac litigation — tracking every development in California’s JCCP, Delaware Superior Court, and Illinois state courts to ensure our clients are positioned for the strongest possible recovery ahead of 2027 bellwether trials.

We handle these cases on a contingency fee basis — you pay nothing unless we win.

This page is for informational purposes only and does not constitute legal advice. Results in prior cases do not guarantee similar outcomes. Consult a qualified attorney for advice specific to your situation.
Our Firm Is Now Accepting Zantac Cancer Cases Free & confidential case evaluation — you pay nothing unless we win.
Get Your Free Case Evaluation